Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
Year: 2001
Type: article
Source: PubMed
Authors: V Shridhar, K C Bible, J Staub, R Avula, Y K Lee, K Kalli, H Huang, L C Hartmann, S H Kaufmann, D I Smith
Institution: Mayo Clinic
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W1492521210
